Computerized Chemosensory-Based Orbitofrontal Cortex (CBOT) for Opioid Use Disorder

Clinical trial NCT04850664 · UNKNOWN

Trial details

NCT number: NCT04850664
Sponsor: Evon Medics LLC
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Opioid Use Disorder, Moderate Opioid Use Disorder, Severe Withdrawal Symptoms Craving Negative Affectivity

Start date: 2021-03-26
Primary completion: 2022-11-30
Enrollment: 190

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.